Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Prednisolone in Minimal Change Disease
NCT00982072Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Dec 2009
- Primary completion
- Oct 2019
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in minimal change disease (MCD), sponsored by Imperial College Healthcare NHS Trust. Started Dec 2009; status: completed.
02
Drugs
tacrolimus
03
Conditions
minimal change disease (MCD)
Beyond the preview
Go deeper on NCT00982072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982072.